I  Synecor


     Office Locations:

1340 Environ Way
Chapel Hill, NC 27517
Phone: 919-883-3220



  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 2000, Synecor, LLC is a privately held, business accelerator focused on creating highly proprietary, disruptive technologies in the largest medical device and combination drug/device markets. Synecor evolved from the confluence of several synergistic strategic relationships, initially in the field of interventional cardiology, but has expanded its field to include all medical specialties such as obesity, spine therapeutics, and more. Synecor was founded by Dr. Richard Stack after two decades of collaboration with leading cardiologists, clinician-inventors, and scientists from across the nation and as an outgrowth of close working relationships among corporate leaders in the medical device industry, and experts at Duke University. Mr. William Starling, a well-known Silicon Valley medical device entrepreneur/executive with a successful 27-year career in the high technology cardiovascular device industry, partnered with Dr. Stack to co-manage Synecor and form strategic relationships with leading venture capital partnerships (Delphi Ventures and Frazier & Company) and a leading investment bank (Deutsche Banc Alex. Brown). The firm has an additional office in North Carolina.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    R. Frederick McCoy, Jr. Vice Chairman
    Richard S. Stack MD, FACC President
    W. Randolph Chitwood, Jr. M.D. MD Clinical Partner
    William N. Starling Chief Executive Officer


    Portfolio companies include:


    Recent News: